Acta Pharmacologica Sinica 2006 April; 27 (4): 499-505; doi: 10.1111/j.1745-7254.2006.00303.x

 
Original Article
[ Full text ]
 
Difference in oral absorption of ginsenoside Rg1 between in vitro and in vivo models
 

Min HAN, Xiao-ling FANG1

Department of Pharmaceutics, School of Pharmacy, Fudan University, Shanghai 200032, China

 

Aim: To clarify the cause of poor oral absorption of ginsenoside Rg1 (Rg1), the active ingredient in Panax notoginseng saponins (PNS) used for treating hemorrhage.

 

Methods: Caco-2 cell monolayers were used as an in vitro model to study the transport mechanism of Rg1 across the intestinal mucosa. Moreover, the serum concentration-time profiles after peroral (po), intraduodenal (id), portal venous (pv) and tail venous (iv) administration of Rg1 in rats were compared to evaluate the first-pass effects in the stomach, intestine, and liver.

 

Results: Uptake of Rg1 by Caco-2 cell monolayers was temperature-dependent, but was not influenced by cyclosporin A. The change in the apical pH produced no obvious effect on the uptake of Rg1. The uptake and transport of Rg1 was non-saturable; whereas the flux from the apical compartment to the basolateral compartment (A-B) increased in a linear manner with the increase in concentration, indicating passive transport. An apparent permeability coefficient of (2.59±0.17)×10-7 cm/s (C0=1 mg/mL) predicted incomplete absorption. A significant difference was observed between the po (Fpo was 3.29% at a dose of 1500 mg/kg), id (Fid was 6.60% at a dose of 1200 mg/kg) and pv (Fpv was 50.56%) administration methods, and the barrier function of the intestine was more significant than those of the stomach and liver in the absorption process.


Conclusion:
Elimination in the stomach, large intestine and liver contributed to the low oral bioavailability of Rg1, but low membrane permeability might be a more important factor in determining the extent of absorption.

 

Keywords: ginsenoside Rg1; Panax; Caco-2; bioavaila-bility; pharmacokinetics

 

Correspondence to Dr Xiao-ling FANG.
Phn/Fax 86-21-5423-7432.
E-mail xlfang@shmu.edu.cn
Received 2005-09-30     Accepted 2005-12-21

[ Full text ]
 

Copyright©APS 2009
Add: 294 Tai-Yuan Road, Shanghai 200031, China
Phn: 86-21-5492-2821  Fax: 86-21-5492-2823
E-mail: aps@mail.shcnc.ac.cn